Ventas, Inc. (VTR) Tops Q3 FFO by 6c, Raises FY11 FFO Guidance
Tweet
Share
E-mailGet Alerts VTR Hot Sheet
Price: $90.66 -1.18%
EPS Growth %: -6.7%
Financial Fact:
Medical office buildings: 158.27M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -6.7%
Financial Fact:
Medical office buildings: 158.27M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Ventas, Inc. (NYSE: VTR) reported Q3 FFO of $0.88, $0.06 better than the analyst estimate of $0.82. Revenue for the quarter came in at $565.96 million versus the consensus estimate of $533.33 million.
Ventas, Inc. sees FY2011 FFO of $3.34-$3.36, versus prior guidance of $3.17-$3.23 and the consensus of $3.15.
Ventas, Inc. sees FY2011 FFO of $3.34-$3.36, versus prior guidance of $3.17-$3.23 and the consensus of $3.15.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Ventas (VTR) at Equalweight
- Ionis Pharmaceuticals (IONS) reaffirms guidance
- Northern Technologies (NTIC) Misses Q3 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
